Hepatolithiasis: analysis of Japanese nationwide surveys over a period of 40 years.
The aims of the present study are to clarify the changes in clinicopathologic features, diagnosis and treatment for hepatolithiasis, and propose an appropriate management strategy in Japan. The research group conducted nationwide surveys seven times in the past over a period of 40 years. Furthermore, a cohort was followed up in 2010. We analyzed the clinical features, diagnosis tools, treatment procedures, outcomes, and predictive factors for cholangiocarcinoma. Surgery was the primary method for hepatolithiasis up to 1998, and the frequency of its use has decreased since then. In 2011, 66.7% of hepatolithiasis patients were treated using nonsurgical approaches. In addition, endoscopic retrograde cholangiography (ERC) with stone extraction was the most frequently performed procedure (22.7%). However, the incidences of residual stone and recurrent stone after ERC with stone extraction were higher than those after percutaneous transhepatic cholangioscopic lithotomy and surgery. Bile duct stricture and dilatation during follow up were significant risk factors for stone recurrences. In the cohort study, stone removal only and age >65 years were significant factors for the development of cholangiocarcinoma. In patients without a history of cholangioenterostomy, left-lobe-type stones were a risk factor, and hepatectomy reduced the risk of the development of cholangiocarcinoma significantly. Nonsurgical treatment may be performed as the first-line treatment for hepatolithiasis. Surgery should be performed on patients who were treated incompletely after nonsurgical treatment. However, hepatectomy may be recommended for patients with left-lobe-type stones and without a history of cholangioenterostomy.
Department of Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan. ysuzuki@ks.kyorin-u.ac.jp.
Yutaka
Y
Suzuki
Toshiyuki
T
Mori
Masaaki
M
Yokoyama
Tetsuya
T
Nakazato
Nobutsugu
N
Abe
Yasuni
Y
Nakanuma
Hirohito
H
Tsubouchi
Masanori
M
Sugiyama
D001650:Bile Duct Neoplasms / Q000453:epidemiology / Q000209:etiology; D001653:Bile Ducts, Intrahepatic; D018281:Cholangiocarcinoma / Q000453:epidemiology / Q000209:etiology; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D007564:Japan / Q000453:epidemiology; D020347:Lithiasis / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008107:Liver Diseases / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012307:Risk Factors
Cholangiocarcinoma; Diagnostic imaging; Hepatolithiasis; Japanese nationwide survey